Lemon said "IF the trial goes as expected". I would also add that with such a long history of positive science backing B yes longs expect a level of success. Our Covid-19 trial will give us the answer on how successful B ends up. The current anti-viral bar is set low. In my opinion I would also expect share price to keep increasing from pennies to dollars.
The trial is expected to succeed by the company and shareholders. I speak from that perspective as a shareholder. We would not waste the time and money to run the trial if it was not expected to succeed.
Prurisol was expected to succeed and it failed miserably. The trial did not go as expected by the company and shareholders.
The result may not be success but the expectation certainly is.
Any shareholder who expects the trial to fail should probably be taking advantage of the prices we're going to see over the coming weeks to get out ahead.
News 
Market Data 
Discover 
AI
